X-153930002-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_003491.4(NAA10):c.693C>T(p.Ser231=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000613 in 1,207,226 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 35 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000065 ( 0 hom. 34 hem. )
Consequence
NAA10
NM_003491.4 synonymous
NM_003491.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.62
Genes affected
NAA10 (HGNC:18704): (N-alpha-acetyltransferase 10, NatA catalytic subunit) N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
ARHGAP4 (HGNC:674): (Rho GTPase activating protein 4) This gene encodes a member of the rhoGAP family of proteins which play a role in the regulation of small GTP-binding proteins belonging to the RAS superfamily. The protein encoded by the orthologous gene in rat is localized to the Golgi complex and can redistribute to microtubules. The rat protein stimulates the activity of some Rho GTPases in vitro. Genomic deletions of this gene and a neighboring gene have been found in patients with nephrogenic diabetes insipidus. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant X-153930002-G-A is Benign according to our data. Variant chrX-153930002-G-A is described in ClinVar as [Benign]. Clinvar id is 2988791.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.62 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000271 (3/110755) while in subpopulation SAS AF= 0.000794 (2/2520). AF 95% confidence interval is 0.00014. There are 0 homozygotes in gnomad4. There are 1 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAdExome4 at 34 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA10 | NM_003491.4 | c.693C>T | p.Ser231= | synonymous_variant | 8/8 | ENST00000464845.6 | NP_003482.1 | |
NAA10 | NM_001256120.2 | c.675C>T | p.Ser225= | synonymous_variant | 8/8 | NP_001243049.1 | ||
NAA10 | NM_001256119.2 | c.648C>T | p.Ser216= | synonymous_variant | 7/7 | NP_001243048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA10 | ENST00000464845.6 | c.693C>T | p.Ser231= | synonymous_variant | 8/8 | 1 | NM_003491.4 | ENSP00000417763 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000271 AC: 3AN: 110755Hom.: 0 Cov.: 22 AF XY: 0.0000303 AC XY: 1AN XY: 32951
GnomAD3 genomes
AF:
AC:
3
AN:
110755
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
32951
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000820 AC: 15AN: 182979Hom.: 0 AF XY: 0.000148 AC XY: 10AN XY: 67477
GnomAD3 exomes
AF:
AC:
15
AN:
182979
Hom.:
AF XY:
AC XY:
10
AN XY:
67477
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000648 AC: 71AN: 1096471Hom.: 0 Cov.: 31 AF XY: 0.0000940 AC XY: 34AN XY: 361883
GnomAD4 exome
AF:
AC:
71
AN:
1096471
Hom.:
Cov.:
31
AF XY:
AC XY:
34
AN XY:
361883
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000271 AC: 3AN: 110755Hom.: 0 Cov.: 22 AF XY: 0.0000303 AC XY: 1AN XY: 32951
GnomAD4 genome
AF:
AC:
3
AN:
110755
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
32951
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 16, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at